In conjunction with the regulatory approval, IntelliGenome has appointed Velez Lab S.A.S. as its exclusive distribution partner for Colombia under a long-term commercial agreement focused on expanding access to innovative tuberculosis diagnostic solutions throughout the country.

The CRISPR-TB Blood Test is a blood-based molecular diagnostic designed to detect cell-free DNA from the Mycobacterium tuberculosis complex in patients with suspected tuberculosis. The platform leverages CRISPR technology to support tuberculosis detection from blood samples through both laboratory-based and point-of-care testing approaches, reflecting IntelliGenome’s vision of expanding access to tuberculosis diagnostics across centralized and decentralized healthcare settings.